Hormonal imbalances are a leading cause of health complications in many adults. For both men and women, the complications may be associated with functional issues but, in most cases, the complication of fertility is of a physiological and biochemical deficiency or impairment.
In men who suffer from prostate cancer, the role of hormones plays a key factor in both the development of cancer and the recovery from cancer. Using an FDA approved drug known as Abarelix, many men find some improvement in the risks associated with progressive cancer into the urethral or bladder, or even the risk for bone cancer development.
As a drug that is administered through intramuscular injection, men find the use of Abarelix quite simple and can be administered in the doctor’s office as part of the prostate cancer treatment program. Administration is generally recommended in a series of three injections, each 14 days apart, with maintenance injections every four weeks thereafter.
As with any FDA approved drug, the use of Abarelix, in the treatment of prostate cancer, does not come without side effects. For men, the most common side effects experienced are pain and inflammation at the injection site, the development of constipation, dizziness, headaches and fatigue. In some men, the breast tissue may become sensitive and liver enzyme testing may read abnormal during therapy; hot flashes are also quite common.
For patients who weigh more than 225 pounds, weight loss is required before Abarelix can be used as part of the prostate treatment program. In addition, men who suffer from cardiovascular complications, and require the use of drugs such as quinidine, procainamide or sotalol, the use of Abarelix is not indicated.
Allergic reactions to Abarelix may also occur with most common side effects being that of hives, excessive itching and even low blood pressure or syncope. If any of these symptoms set in, consult a healthcare professional immediately as the use of Abarelix may need to be discontinued on the scheduled dosing.
As with any complication associated with prostate cancer, it is important to not only prevent the disease but also treat the complication and avoid risks for the cancer spreading. Because prostate cancer can spread to the urological system and the bones, the use of Abarelix may provide for a convenient, once-per-month, dosing injection that will significantly reduce the risk for metastases. With the risk for recurring prostate cancer, Abarelix may also work to promote remission and prevent further health complications of the prostate.